Lobbying client

IMMUNOME INC.

biopharmaceutical company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
5
Filed by
2
Reported in-house
—
Reported by firms
$20,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2021 to 2022

Filings

3 filings for 2021, newest first.
Filing Filed by Amount
4th Quarter - Termination (No Activity)
4th Quarter 2021
DUANE MORRIS GOVERNMENT STRATEGIES — reported
3rd Quarter - Report
3rd Quarter 2021
DUANE MORRIS GOVERNMENT STRATEGIES $10,000 reported
Registration
3rd Quarter 2021
DUANE MORRIS GOVERNMENT STRATEGIES — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
DUANE MORRIS GOVERNMENT STRATEGIES 2 $10,000
K&L GATES, LLP 1 $10,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 4

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 8295 117th 1
S. 2640 117th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.